» Articles » PMID: 21300461

Volumetric-modulated Arc Therapy for Stereotactic Body Radiotherapy of Lung Tumors: a Comparison with Intensity-modulated Radiotherapy Techniques

Overview
Specialties Oncology
Radiology
Date 2011 Feb 9
PMID 21300461
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To demonstrate the potential of volumetric-modulated arc therapy (VMAT) compared with intensity-modulated radiotherapy (IMRT) techniques with a limited number of segments for stereotactic body radiotherapy (SBRT) for early-stage lung cancer.

Methods And Materials: For a random selection of 27 patients eligible for SBRT, coplanar and noncoplanar IMRT and coplanar VMAT (using SmartArc) treatment plans were generated in Pinnacle(3) and compared. In addition, film measurements were performed using an anthropomorphic phantom to evaluate the skin dose for the different treatment techniques.

Results: Using VMAT, the delivery times could be reduced to an average of 6.6 min compared with 23.7 min with noncoplanar IMRT. The mean dose to the healthy lung was 4.1 Gy for VMAT and noncoplanar IMRT and 4.2 Gy for coplanar IMRT. The volume of healthy lung receiving>5 Gy and >20 Gy was 18.0% and 5.4% for VMAT, 18.5% and 5.0% for noncoplanar IMRT, and 19.4% and 5.7% for coplanar IMRT, respectively. The dose conformity at 100% and 50% of the prescribed dose of 54 Gy was 1.13 and 5.17 for VMAT, 1.11 and 4.80 for noncoplanar IMRT and 1.12 and 5.31 for coplanar IMRT, respectively. The measured skin doses were comparable for VMAT and noncoplanar IMRT and slightly greater for coplanar IMRT.

Conclusions: Coplanar VMAT for SBRT for early-stage lung cancer achieved plan quality and skin dose levels comparable to those using noncoplanar IMRT and slightly better than those with coplanar IMRT. In addition, the delivery time could be reduced by ≤70% with VMAT.

Citing Articles

Multicriteria optimization achieves superior normal tissue sparing in volumetric modulated arc therapy for gastric cancer.

He L, Gao X, Li T, Li X, Sun X, Wei Z BMC Cancer. 2024; 24(1):1376.

PMID: 39528982 PMC: 11552167. DOI: 10.1186/s12885-024-13067-y.


Feasibility of a Single-Fraction Stereotactic Dose of 30 Gy to Solitary Lung Lesions on Halcyon.

Misa J, Knight J, Pokhrel D Cureus. 2024; 16(5):e59535.

PMID: 38826981 PMC: 11144037. DOI: 10.7759/cureus.59535.


Stereotactic body radiotherapy with volumetric intensity-modulated arc therapy and flattening filter-free beams: dosimetric considerations.

Brekner M, Imhoff D, Rodel C, Filmann N, Licher J, Ramm U Strahlenther Onkol. 2023; 200(4):346-357.

PMID: 38092967 PMC: 10965745. DOI: 10.1007/s00066-023-02181-8.


Initial clinical experience building a dual CT- and MR-guided adaptive radiotherapy program.

Price A, Schiff J, Laugeman E, Maraghechi B, Schmidt M, Zhu T Clin Transl Radiat Oncol. 2023; 42:100661.

PMID: 37529627 PMC: 10388162. DOI: 10.1016/j.ctro.2023.100661.


Machine-learning-based prediction of the effectiveness of the delivered dose by exhale-gated radiotherapy for locally advanced lung cancer: The additional value of geometric over dosimetric parameters alone.

Guberina N, Pottgen C, Santiago A, Levegrun S, Qamhiyeh S, Ringbaek T Front Oncol. 2023; 12:870432.

PMID: 36713497 PMC: 9880443. DOI: 10.3389/fonc.2022.870432.